Comment on

• Impaired color vision in cocaine-withdrawn patients.

  Desai P, Roy M, Roy A, Brown S, Smelson D. Desai P, et al. Arch Gen Psychiatry. 1997 Aug;54(8):696-9. doi: 10.1001/archpsyc.1997.01830200020003. Arch Gen Psychiatry. 1997. PMID: 9283503
• Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.

  Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A. Cornelius JR, et al. Arch Gen Psychiatry. 1997 Aug;54(8):700-5. doi: 10.1001/archpsyc.1997.01830200024004. Arch Gen Psychiatry. 1997. PMID: 9283504 Clinical Trial.
• Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders.

  Miner CR, Rosenthal RN, Hellerstein DJ, Muenz LR. Miner CR, et al. Arch Gen Psychiatry. 1997 Aug;54(8):706-12. doi: 10.1001/archpsyc.1997.01830200030005. Arch Gen Psychiatry. 1997. PMID: 9283505
• Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.

  Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Schottenfeld RS, et al. Arch Gen Psychiatry. 1997 Aug;54(8):713-20. doi: 10.1001/archpsyc.1997.01830200041006. Arch Gen Psychiatry. 1997. PMID: 9283506 Clinical Trial.
• The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods.

  Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz L, Thase ME, Weiss RD, Gastfriend DR, Woody G, Barber JP, Butler SF, Daley D, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT. Crits-Christoph P, et al. Arch Gen Psychiatry. 1997 Aug;54(8):721-6. doi: 10.1001/archpsyc.1997.01830200053007. Arch Gen Psychiatry. 1997. PMID: 9283507 Clinical Trial.
• Problem-service 'matching' in addiction treatment. A prospective study in 4 programs.

  McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O'Brien CP. McLellan AT, et al. Arch Gen Psychiatry. 1997 Aug;54(8):730-5. doi: 10.1001/archpsyc.1997.01830200062008. Arch Gen Psychiatry. 1997. PMID: 9283508 Clinical Trial.
• Naltrexone and alcohol dependence. Role of subject compliance.

  Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP. Volpicelli JR, et al. Arch Gen Psychiatry. 1997 Aug;54(8):737-42. doi: 10.1001/archpsyc.1997.01830200071010. Arch Gen Psychiatry. 1997. PMID: 9283509 Clinical Trial.